Daniel Grosslight
Stock Analyst at Citigroup
(1.20)
# 3,433
Out of 4,711 analysts
96
Total ratings
31.48%
Success rate
-10.37%
Average return
Main Sectors:
Stocks Rated by Daniel Grosslight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MCK McKesson | Maintains: Buy | $630 → $713 | $579.74 | +22.99% | 6 | Nov 13, 2024 | |
| HCAT Health Catalyst | Maintains: Buy | $9 → $11 | $7.09 | +48.10% | 7 | Nov 13, 2024 | |
| GDRX GoodRx Holdings | Maintains: Buy | $10 → $7 | $4.44 | +57.66% | 6 | Nov 13, 2024 | |
| EVH Evolent Health | Maintains: Buy | $33 → $21 | $11.41 | +84.05% | 3 | Nov 13, 2024 | |
| AGL agilon health | Maintains: Sell | $2.5 → $1.75 | $1.97 | -11.17% | 3 | Nov 13, 2024 | |
| OMI Owens & Minor | Maintains: Buy | $21 → $19 | $12.52 | +47.76% | 5 | Nov 5, 2024 | |
| MPLN MultiPlan | Maintains: Neutral | $17 → $10 | $6.02 | +66.11% | 8 | Sep 23, 2024 | |
| CAH Cardinal Health | Maintains: Neutral | $115 → $107 | $118.28 | -9.54% | 4 | Jul 19, 2024 | |
| HIMS Hims & Hers Health | Downgrades: Neutral | $16 → $20 | $26.20 | -23.66% | 6 | May 22, 2024 | |
| PRVA Privia Health Group | Initiates: Buy | $25 | $20.07 | +24.56% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $17 → $9.4 | $3.27 | +187.46% | 10 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $21 → $19 | $9.44 | +101.27% | 10 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $37 | $25.16 | +47.06% | 5 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $10 | $8.32 | +20.19% | 7 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $7 → $8 | $11.21 | -28.64% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1.25 | $3.03 | -58.75% | 5 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7 → $3.5 | $2.98 | +17.45% | 2 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $10.28 | +26.46% | 1 | Dec 11, 2019 |
McKesson
Nov 13, 2024
Maintains: Buy
Price Target: $630 → $713
Current: $579.74
Upside: +22.99%
Health Catalyst
Nov 13, 2024
Maintains: Buy
Price Target: $9 → $11
Current: $7.09
Upside: +48.10%
GoodRx Holdings
Nov 13, 2024
Maintains: Buy
Price Target: $10 → $7
Current: $4.44
Upside: +57.66%
Evolent Health
Nov 13, 2024
Maintains: Buy
Price Target: $33 → $21
Current: $11.41
Upside: +84.05%
agilon health
Nov 13, 2024
Maintains: Sell
Price Target: $2.5 → $1.75
Current: $1.97
Upside: -11.17%
Owens & Minor
Nov 5, 2024
Maintains: Buy
Price Target: $21 → $19
Current: $12.52
Upside: +47.76%
MultiPlan
Sep 23, 2024
Maintains: Neutral
Price Target: $17 → $10
Current: $6.02
Upside: +66.11%
Cardinal Health
Jul 19, 2024
Maintains: Neutral
Price Target: $115 → $107
Current: $118.28
Upside: -9.54%
Hims & Hers Health
May 22, 2024
Downgrades: Neutral
Price Target: $16 → $20
Current: $26.20
Upside: -23.66%
Privia Health Group
Apr 22, 2024
Initiates: Buy
Price Target: $25
Current: $20.07
Upside: +24.56%
Apr 16, 2024
Maintains: Neutral
Price Target: $17 → $9.4
Current: $3.27
Upside: +187.46%
Feb 21, 2024
Maintains: Neutral
Price Target: $21 → $19
Current: $9.44
Upside: +101.27%
Sep 7, 2023
Maintains: Buy
Price Target: $40 → $37
Current: $25.16
Upside: +47.06%
Aug 9, 2023
Maintains: Neutral
Price Target: $9 → $10
Current: $8.32
Upside: +20.19%
Aug 4, 2023
Downgrades: Sell
Price Target: $7 → $8
Current: $11.21
Upside: -28.64%
Apr 28, 2023
Maintains: Neutral
Price Target: $1.5 → $1.25
Current: $3.03
Upside: -58.75%
Nov 16, 2021
Downgrades: Neutral
Price Target: $7 → $3.5
Current: $2.98
Upside: +17.45%
Dec 11, 2019
Initiates: Outperform
Price Target: $13
Current: $10.28
Upside: +26.46%